Value Research Online

This pharma bluechip is springing back to life. Is it worth your consideration?

Tue, 28 May 2024 13:55:07 +0530

After grappling with a series of challenges the pharma bluechip, Lupin, is finally restoring its health. Should you consider investing in it?

Stock Rating update, March 22, 2024

Tue, 26 Mar 2024 13:10:16 +0530

Actionable insight based on valuation without losing sight of the fundamentals

Companies that went from hero to zero

Mon, 01 Jan 2024 11:46:24 +0530

Our 'Stock Ratings' tool unveils insights into Lupin, Zee Entertainment, and The Ramco Cements' decline and the factors behind their struggling growth.

The homemaker investor

Mon, 09 Aug 2021 07:00:00 +0530

Bithi Patnaik's story is one of exploitation and mis-selling by banks, yet she chose not to lose hope and became an informed investor

Big shifts

Wed, 04 Jul 2018 06:54:15 +0530

Here are some companies that have significantly grown and shrunk in size over the last 10 years

Shot in the arm

Wed, 08 Feb 2017 07:26:25 +0530

Riding on a strong ANDA pipeline, benefits from generics and gains from Gavis, Lupin is expected to see its earnings compound at 30 per cent>

Fall of Pharma

Thu, 13 Oct 2016 12:22:16 +0530

The pharma sector, which once used to be the star of the Street, has been witnessing bad times>

Who wins in India: Value or Growth?

Fri, 15 Jul 2016 13:12:10 +0530

This comparison pits told old rivals against each other using MSCI India Indices. Time determines the answer>

FIIs Vs DIIs: Different strokes

Fri, 20 May 2016 10:30:00 +0530

An analysis of stock market transactions reveals that FIIs and domestic institutions are taking contrasting views on sectors>

Small is beautiful in pharma

Thu, 10 Dec 2015 11:38:29 +0530

With high numbers of ANDAs, mid-rung pharma companies could outperform their larger peers in the future>

Delivering big-bang growth

Wed, 09 Dec 2015 11:35:00 +0530

Lupin started as a TB specialist and grew itself over the years through acquisitions. Things went on so well that it made its shareholders as rich as Croesus>

The most rewarding stocks of the decade

Mon, 30 Nov 2015 11:53:00 +0530

Each of these companies has faced tough periods but each has overcome them. See what the future holds for these multibaggers>

The quest for value

Tue, 20 Oct 2015 17:56:55 +0530

There is little value in the stocks of the three main defensive sectors: FMCG, pharma and technology

Fighting Fit

Mon, 18 May 2015 02:00:00 +0530

Lupin is third-largest player in the domestic formulations space, with a field force of over 5,000 medical representatives>

Pink of Health

Tue, 07 Aug 2012 16:01:00 +0530

Lupin already has a significant market share in India, and is now looking to expand its presence abroad…>

Blue-blooded blue chips

Mon, 23 Aug 2010 11:17:00 +0530

Warren Buffett has said that it is okay to pay a fair price for a good company. Here are the blue-chips. But do avoid overpaying for them>

We Appreciate Depreciating Rupee

Mon, 21 Jul 2008 17:16:00 +0530

The falling rupee might not be good for the economy, but for the export-oriented sectors it spells good news>

Stocks in the news

Sat, 15 Sep 2007 14:34:00 +0530

Here is a brief compilation on stock specific news and other reports and data that had a bearing on the market last week. >